Atsushi Kurihara - Concepedia

Author

Atsushi Kurihara

Daiichi-Sankyo (Japan)

Also Known As

A Kurihara, A. KURIHARA, A. Kurihara, ATSUSHI KURIHARA, Atsushi KURIHARA, Atsushi Kurihara, Ayano Kurihara

128

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Daiichi-Sankyo (Japan)Eli Lilly (United States)Yokohama University of Pharmacy Daiichi Sankyo (Germany)University of California, Los Angeles

About

Atsushi Kurihara is an author at Daiichi-Sankyo (Japan) specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	1.2K
2	Engineering	3	3	175
3	Natural Sciences	3	3	76
4	Social Sciences	2	2	114
5	Health Sciences	1	1	31

Atsushi Kurihara

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite Miho Kazui, Yumi Nishiya, Tomoko Ishizuka, Drug Metabolism and Disposition	2009	808
INTERACTIONS OF TWO MAJOR METABOLITES OF PRASUGREL, A THIENOPYRIDINE ANTIPLATELET AGENT, WITH THE CYTOCHROMES P450 Jessica Rehmel, James A. Eckstein, Nagy A. Farid, Drug Metabolism and Disposition	2006	263
A Zone Classification System for Risk Assessment of Idiosyncratic Drug Toxicity Using Daily Dose and Covalent Binding Shintaro Nakayama, Ryo Atsumi, Hideo Takakusa, Drug Metabolism and Disposition Drug SafetySubstance AbusePredictive ToxicologyForensic ToxicologyPharmacology	2009	246
The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel’s active metabolite Atsuhiro Sugidachi, Taketoshi Ogawa, Atsushi Kurihara, Journal of Thrombosis and Haemostasis Molecular PharmacologyThrombosisEfficient GenerationBiochemistryBlood Platelet	2007	218
The Disposition of Prasugrel, a Novel Thienopyridine, in Humans Nagy A. Farid, Richard L. Smith, Todd A. Gillespie, Drug Metabolism and Disposition	2007	211
Transport Across the Primate Blood-Brain Barrier of a Genetically Engineered Chimeric Monoclonal Antibody to the Human Insulin Receptor M J Coloma, Hwajeong Lee, Atsushi Kurihara, Pharmaceutical Research	2000	199
Predictability of Idiosyncratic Drug Toxicity Risk for Carboxylic Acid-Containing Drugs Based on the Chemical Stability of Acyl Glucuronide Ryoko Sawamura, Noriko Okudaira, Kengo Watanabe, Drug Metabolism and Disposition	2010	127
Quantitative determination of clopidogrel active metabolite in human plasma by LC–MS/MS Makoto Takahashi, Henrianna Pang, Kiyoshi Kawabata, Journal of Pharmaceutical and Biomedical Analysis BiochemistryClopidogrel Active MetaboliteMedicineBioanalysisMass Spectrometry	2008	126
A Possible Mechanism for the Differences in Efficiency and Variability of Active Metabolite Formation from Thienopyridine Antiplatelet Agents, Prasugrel and Clopidogrel Katsunobu Hagihara, Miho Kazui, Atsushi Kurihara, Drug Metabolism and Disposition	2009	121
Prediction of Fluoroquinolone-Induced Elevation in Serum Creatinine Levels: A Case of Drug–Endogenous Substance Interaction Involving the Inhibition of Renal Secretion Yoshinori Imamura, Nobuyuki Murayama, Noriko Okudaira, Clinical Pharmacology & Therapeutics	2010	106

Page 1